May 06, 2025

FDA Approves TAVR Platform for Asymptomatic AS

The FDA has approved the SAPIEN 3 TAVR platform for patients with asymptomatic severe aortic stenosis based on data from the EARLY TAVR trial.

Conexiant

May 06, 2025

Anemia Linked to Hidden Heart Strain in RA

A new study found that 1 in 3 rheumatoid arthritis patients with normal heart function on standard tests had hidden heart strain detectable only through advanced imaging, with anemia emerging as the strongest predictor.

Conexiant

May 06, 2025

AML: MRD Testing Led to Survival Benefits in Subset of Patients

Sequential molecular MRD testing and monitoring led to a survival benefit among younger patients with AML and NPM1 or FLT3-ITD mutations, according to the results of a study published in The Lancet Ha...

The ASCO Post

May 06, 2025

New Treatment Approach Could Enhance Care for Aggressive Relapsed/Refractory T- and NK-Cell Lymphomas

Investigators have uncovered how a specific sequence of cancer therapies could improve outcomes among patients with relapsed/refractory mature T- and natural killer (NK)-cell lymphomas.

The ASCO Post

May 06, 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant

May 06, 2025

Liver Stiffness Drop Tied to Inflammation, Not Fibrosis 

In a 72-week study of hepatitis B patients, researchers found liver stiffness declines were driven by improved inflammation, not actual fibrosis regression.

Conexiant

May 05, 2025

Ustekinumab Biosimilar Receives Interchangeability Approval

Selarsdi (ustekinumab-aekn) was approved by the FDA as an interchangeable biosimilar to Stelara (ustekinumab) for all approved indications, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Conexiant

May 05, 2025

Financial Toxicity Tumor Board: Can It Reduce Treatment Costs?

The Atrium Health Levine Cancer Institute established a Financial Toxicity Tumor Board in 2019. The board is the first known institutional-level intervention of its kind and functions like a tradition...

The ASCO Post

May 05, 2025

Links Between HPV and Thyroid Eye Disease

Researchers find “molecular mimicry between HPV capsid protein and key autoimmunity targets in TED,” but further studies are needed to confirm the connection

Conexiant